kentucky glp-1 diarrhea class action Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus SGLT2 vs GLP-1: Individualizing Diabetes,
Description
A.MisraM.MickleyD.GleysteenS.HerzogD
Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced chronic kidney disease
You can conveniently track your engagement progress using a specialized tool in the mobile app
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) present an important new treatment option for patients with obesity, and act primarily by decreasing caloric intake through appetite suppression
